Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Dana Provaznikova"'
Autor:
Jan Louzil, Jana Stikarova, Dana Provaznikova, Ingrid Hrachovinova, Tereza Fenclova, Jan Musil, Martin Radek, Jirina Kaufmanova, Vera Geierova, Eliska Ceznerova, Peter Salaj, Roman Kotlin
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 14386
A single-center study was conducted on 120 patients with inherited disorders of primary hemostasis followed at our hematological center. These patients presented a variety of bleeding symptoms; however, they had no definitive diagnosis. Establishing
Autor:
Tereza Fenclova, Miloslava Matyskova, Dana Provaznikova, Frantisek Marecek, Vera Geierova, Zuzana Kovarova-Kudrnova, Ingrid Hrachovinova
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. :100194
Autor:
Eva Drbohlavová, Dagmar Grančarová, Ingrid Hrachovinova, M. Šlechtová, Irena Čápová, Dana Provaznikova, Miloslava Matýšková
Publikováno v:
Thrombosis research. 189
Autor:
Jana Markova, Jana Březinová, Jaroslav Jelinek, Ota Fuchs, Hana Klamova, Zuzana Zemanova, Jiří Schwarz, Dana Provaznikova, Petr Lemež, Iuri Marinov, Arnost Kostecka, Kyra Michalova
Publikováno v:
Acta Haematologica. 126:129-134
Patients with near-tetraploid acute myeloid leukemia (NT-AML) typically have poor survival. We present the case of a 67-year-old Caucasian male with NT-AML M0 who had an unusually long first complete remission of 51 months and an overall survival of
Autor:
Libuse Lizcova, Silvia Izakova, Dana Provaznikova, Jana Březinová, Adela Berkova, Jan Starý, Jitka Filkukova, Kyra Michalova, Iveta Sarova, Eva Malinova, Zuzana Zemanova, Arnost Kostecka, Ota Fuchs, Jacqueline Maaloufová
Publikováno v:
Cancer Genetics and Cytogenetics. 195:150-156
Unusual MLL gene rearrangements were found in bone marrow cells of four patients with acute myeloid leukemia. A combination of conventional and molecular cytogenetic methods were used to describe translocations t(9;12;11)(p22;p13;q23), t(11;19)(q23;p
Autor:
Ota Fuchs, Dana Sponerova, Jana Markova, Michal Kouba, Petr Kobylka, Blazena Krasna, Jitka Filkukova, Jaroslav Cermak, Jacqueline Maaloufová, Radana Neuwirtova, L. Nováková, Jana Brezinova, Anna Jonasova, Dana Provaznikova, Jiri Schwarz, Roman Kotlín, Miroslav Caniga, Arnost Kostecka
Publikováno v:
Blood Cells, Molecules, and Diseases. 43:260-263
C/EBPalpha (CCAAT/enhancer binding protein alpha) belongs to the family of leucine zipper transcription factors and is necessary for transcriptional control of granulocyte, adipocyte and hepatocyte differentiation, glucose metabolism and lung develop
Autor:
Jacqueline Maaloufová, Pavla Cvekova, Jiri Schwarz, Petr Lemez, Ota Fuchs, L. Nováková, Jana Brezinova, Peter Salaj, Petr Kobylka, Jaroslav Cermak, Arnost Kostecka, Jana Markova, Dana Provaznikova, Marcela Kocova, Katerina Benesova, Radana Neuwirtova, Hana Klamova
Publikováno v:
Blood Cells, Molecules, and Diseases. 40:401-405
The transcription factor CCAAT/enhancer binding protein (C/EBP)alpha is a myeloid-specific transcription factor which is required for normal myeloid differentiation. C/EBPalpha is encoded by an intronless gene that is 2783 bp long and maps to human c
Autor:
Iuri Marinov, Magdalena Riedl, Tomáš Seeman, Dana Provaznikova, Michal Malina, Ingrid Hrachovinova, Simon Rittich
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Mutations in genes encoding regulators of the alternative complement pathway (CFH, MCP, C3, CFI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2349b937338d904487ea5e63804cbda
https://avesis.deu.edu.tr/publication/details/c05a9250-cedb-4670-8d79-b3a5b24291b0/oai
https://avesis.deu.edu.tr/publication/details/c05a9250-cedb-4670-8d79-b3a5b24291b0/oai
Autor:
Dana Provaznikova, Vera Geierova, Simon Rittich, Ingrid Hrachovinova, Kamila Zurkova, Dana Mikulenkova, Tereza Kumstyrova, Vaclav Matoska, Roman Kotlín
Publikováno v:
Platelets. 20(5)
Currently, the May-Hegglin anomaly (MHA), Sebastian (SBS), Fechtner (FTNS) and Epstein (EPS) syndrome are considered to be distinct clinical manifestations of a single disease caused by mutations of the MYH9 gene encoding the heavy chain of non-muscl
Publikováno v:
Cardiovascularhematological disorders drug targets. 9(1)
New chemotherapeutic agents are still required to further optimise treatment of leukemia patients. Proteasome inhibition by bortezomib, PR-171 (carfilzomib) and NPI-0052 (salinosporamide A) has been successfully used for the treatment of multiple mye